Apellis Pharmaceuticals (NASDAQ:APLS) reported its Q4 earnings results on Monday, February 28, 2022 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
Apellis Pharmaceuticals missed estimated earnings by 4.55%, reporting an EPS of $-1.61 versus an estimate of $-1.54.
Revenue was up $189.71 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.18 which was followed by a 10.83% increase in the share price the next day.
Here’s a look at Apellis Pharmaceuticals’s past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -1.75 | -1.70 | -1.62 | |
| EPS Actual | -1.57 | -2.72 | -2.32 | 0.93 |
| Revenue Estimate | 7.22M | 810.00K | 2.27M | 96.09M |
| Revenue Actual | 5.65M | 623.00K | 0 | 250.00M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
